Successful Treatment With Ivig Therapy Of Diabetes-Associated Scleredema Severe Progressive Case And Review Of The Literature

Keywords

intravenous immunoglobulin; IVIg; scleredema; therapy; treatment

Abstract

Scleredema is a deposition disorder which presents as diffuse, symmetric, non-pitting skin induration from dermal deposits of glycosaminoglycans (“mucins”). It classically affects the upper back and posterior neck, often causing skin tightness and decreased range of motion. In most patients the clinical course is chronic and treatment options are limited. We report a case of a patient diagnosed with scleredema associated with longstanding insulin dependent diabetes who was treated successfully with IVIg. Additionally, we have reviewed the literature reporting other patients with scleredema treated with IVIg.

Publication Date

7-1-2017

Publication Title

Dermatologic Therapy

Volume

30

Issue

4

Document Type

Article

Personal Identifier

scopus

DOI Link

https://doi.org/10.1111/dth.12504

Socpus ID

85020129229 (Scopus)

Source API URL

https://api.elsevier.com/content/abstract/scopus_id/85020129229

This document is currently not available here.

Share

COinS